SCHEMBL2009653

SCHEMBL2009653

N#CC1CCCN1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6606324 0.98
SCHEMBL6691379 0.84
SCHEMBL8145989 0.75
SCHEMBL8145993 0.75
SCHEMBL6752265 0.73 CYP2D6 (0.44)
SCHEMBL4357889 0.70
SCHEMBL13598576 0.70
SCHEMBL8298016 0.70
SCHEMBL13181713 0.70
SCHEMBL20207147 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104003922-A Substituted pyrrolidine derivative, preparation method thereof and use in medicine UNIV CHINA PHARMA 2014-08-27 CN claimed
EP-1931633-A2 DERIVATIVES OF 3-AZABICYCLO[3.1.0]HEXANE AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS Ranbaxy Laboratories Limited (IN) 2008-06-18 EP claimed
WO-2007029086-A2 DERIVATIVES OF 3-AZABICYCLO[3.1.0]HEXANE AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2007-03-15 WO claimed
US-20060293297-A1 Cyanofluoropyrrolidine derviative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2006-12-28 US claimed
EP-1627870-A1 CYANOFLUOROPYRROLIDINE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-02-22 EP claimed
EP-1406873-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-04-14 EP claimed
WO-2003002531-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-01-09 WO claimed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
CN-110075098-A Purposes of the Li Gelieting in heart and protection renal antidiabetic treatment 勃林格殷格翰国际有限公司 2019-08-02 CN disclosed
CN-104109111-B The preparation method of Tosi acid Bei Gelieting and its intermediate 江苏豪森药业集团有限公司 2019-02-12 CN disclosed
CN-104926706-B Salt of hexahydro pentalene derivative and its preparation method and application 广东东阳光药业有限公司 2017-12-05 CN disclosed
US-9416105-B2 Process for preparation of saxagliptin and its hydrochloride salt AMNEAL PHARMACEUTICALS LLC (US) 2016-08-16 US disclosed
US-20160194282-A1 A Process For Preparation Of Saxagliptin And Its Hydrochloride Salt AMNEAL PHARMACEUTICALS LLC 2016-07-07 US disclosed
EP-1627870-A1 CYANOFLUOROPYRROLIDINE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-02-22 EP disclosed
JP-2005272457-A PHARMACEUTICAL CONTAINING CYANOPYRROLIDINE DERIVATIVE AS ACTIVE INGREDIENT TAISHO PHARMACEUT CO LTD 2005-10-06 JP disclosed
WO-2004101514-A1 CYANOFLUOROPYRROLIDINE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2004-11-25 WO disclosed
EP-1406873-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-04-14 EP disclosed
EP-1399433-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-03-24 EP disclosed
WO-2003002531-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-01-09 WO disclosed
WO-2003002553-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-01-09 WO disclosed